To evaluate the effects of photobiomodulation (PBM) on glycemic control in individuals with type 2 diabetes mellitus (T2DM). Persistent hyperglycemia in T2DM disrupts mitochondrial metabolism, increases oxidative stress, and contributes to metabolic and vascular complications. PBM has emerged as a potential nonpharmacological strategy to modulate mitochondrial function and improve metabolic homeostasis.
Methods:
Recent clinical trials investigating PBM in T2DM were systematically synthesized. Methodological quality was assessed using the Physiotherapy Evidence Database scale, and certainty of evidence was evaluated with the Grading of Recommendations, Assessment, Development, and Evaluation approach.
Results:
PBM, predominantly using red and near-infrared wavelengths, was associated with reductions in fasting glucose, postprandial glucose, and glycated hemoglobin, as well as modulation of hemodynamic and metabolic parameters. Methodological quality ranged from moderate to high, while certainty of evidence was very low to low.
Conclusions:
PBM shows potential as an adjunctive therapy for glycemic control in T2DM, although further well-designed trials are required to strengthen evidence and standardize protocols.
MaglianoDJ, BoykoEJ. IDF Diabetes Atlas 10th edition scientific committee. IDF DIABETES ATLAS, 10th ed. International Diabetes: Brussels; 2021, p. 35914061.
2.
Association AD. Classification and diagnosis of diabetes: Standards of medical care in diabetes—2021. Diabetes Care2021;44:S15–S33.
3.
RodackiM, ZajdenvergL, da Silva JúniorWS, et al.Brazilian guideline for screening and diagnosis of type 2 diabetes: A position statement from the Brazilian Diabetes Society. Diabetol Metab Syndr2025;17(1):78.
4.
SchmidtSK, HemmestadL, MacDonaldCS, LangbergH, ValentinerLS. Motivation and barriers to maintaining lifestyle changes in patients with type 2 diabetes after an intensive lifestyle intervention (the U-TURN trial): A longitudinal qualitative study. Int J Environ Res Public Health2020;17(20):7454.
5.
SigalRJ, KennyGP, WassermanDH, Castaneda-SceppaC, WhiteRD. Physical activity/exercise and type 2 diabetes: A consensus statement from the American Diabetes Association. Diabetes Care2006;29(6):1433–1438.
6.
Galicia-GarciaU, Benito-VicenteA, JebariS, et al.Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci2020;21(17):6275.
7.
LimaJE, MoreiraNC, Sakamoto-HojoET. Mechanisms underlying the pathophysiology of type 2 diabetes: From risk factors to oxidative stress, metabolic dysfunction, and hyperglycemia. Mutat Res Genet Toxicol Environ Mutagen2022;874–875:503437.
8.
MasengaSK, KabweLS, ChakulyaM, KiraboA. Mechanisms of oxidative stress in metabolic syndrome. Int J Mol Sci2023;24(9):7898.
9.
TschiedelB. Complicações crônicas do diabetes. J Bras Med2014;102:7–12.
10.
ZafariJ, SadeghiH, AbbasiniaH, NajjarN, JamaliS, Javani JouniF. Photobiomodulation therapy: A promising treatment for insulin resistance in type 2 diabetes. In Vitro Cell Dev Biol Anim2025;61(6):703–711; doi: 10.1007/s11626-025-01051-0
11.
MaghfourJ, MineroffJ, OzogDM, et al.Evidence-based consensus on the clinical application of photobiomodulation. J Am Acad Dermatol2025;93(2):429–443.
12.
KaruT. Primary and secondary mechanisms of action of visible to near-IR radiation on cells. J Photochem Photobiol B1999;49(1):1–17.
13.
MarcolinoAM, HendlerKG, BarbosaRI, NevesL, KurikiHU, DutraRC. Effect of photobiomodulation therapy (660 nm and 830 nm) on carrageenan-induced edema and pain behavior in mice. BRJP2022;5(3):206–212.
14.
AndersJJ, AranyPR, BaxterGD, LanzafameRJ. Light-emitting diode therapy and low-level light therapy are photobiomodulation therapy. Photobiomodul Photomed Laser Surg2019;37(2):63–65.
15.
HamblinMR. Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophys2017;4:337.
16.
FerraresiC, HamblinMR, ParizottoNA. Low-level laser (light) therapy (LLLT) on muscle tissue: Performance, fatigue and repair benefited by the power of light. Photonics Lasers Med2012;1(4):267–286.
17.
WangK, ZhaoH, ZhaoX, et al.Photobiomodulation for diabetes and its complications: A review of general presentation, mechanisms and efficacy. Ann Med2024;56(1):2433684.
18.
HadebeL, HoureldNN. Therapeutic potential of photobiomodulation in diabetic complications. Discov Med2024;36(189):1987–1997.
19.
SantosC, RochaR, HazimeFA, CardosoVS. A systematic review and meta-analysis of the effects of low-level laser therapy in the treatment of diabetic foot ulcers. Int J Low Extrem Wounds2021;20(3):198–207.
20.
MgwenyaTN, AbrahamseH, HoureldNN. Photobiomodulation studies on diabetic wound healing: An insight into the inflammatory pathway in diabetic wound healing. Wound Repair Regen2025;33(1):e13239.
21.
FreireBL, AbreuLG, CostaFO, CotaLOM, Esteves-LimaRP. Effect of photobiomodulation adjunct to periodontal therapy on individuals with type 2 diabetes mellitus regarding periodontal clinical parameters: A systematic review and meta-analysis. Lasers Med Sci2023;38(1):116.
22.
PerrierQ, MoroC, LablancheS. Diabetes in spotlight: Current knowledge and perspectives of photobiomodulation utilization. Front Endocrinol (Lausanne)2024;15:1303638.
23.
KoradaHY, AroraE, MaiyaGA, et al.Effectiveness of photobiomodulation therapy on neuropathic pain, nerve conduction and plantar pressure distribution in diabetic peripheral neuropathy-a systematic review. Curr Diabetes Rev2023;19(9):e290422204244–e9.
24.
RochaM, de OliveiraLRS, XavierDM, et al.The effects of different doses of single‐and dual‐wavelength whole‐body photobiomodulation on metabolic parameters in obese mice. Photochem Photobiol2025;101(3):746–761.
25.
SilvaG, FerraresiC, de AlmeidaRT, et al.Insulin resistance is improved in high‐fat fed mice by photobiomodulation therapy at 630 nm. J Biophotonics2020;13(3):e201960140.
26.
CostaJSR, SilvaG, GuimarãesIC, et al.Photobiomodulation enhances the effect of strength training on insulin resistance regardless of exercise volume in mice fed a high‐fat diet. J Biophotonics2024;17(12):e202400274.
27.
HigginsJPT, ThomasJ, ChandlerJ, et al.Cochrane handbook for systematic reviews of interventions Cochrane 2024;version 6.5. Cochrane; 2024.
28.
PageMJ, McKenzieJE, BossuytPM, et al.The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ2021;372:n71.
29.
PEDro. PEDro scale. Physiotherapy Evidence Database (PEDro).
30.
HigginsJP, SterneJA, SavovicJ, et al.A revised tool for assessing risk of bias in randomized trials. Cochrane Database Syst Rev2016;10:29–31.
31.
Ignacio NeumannSB, MeerpohlJ, DavoliM, et al.Schünemann. Overview of the GRADE approach. In: The GRADE Book version 10. 2024.
32.
SerryZ, El-KhashabS, El-MonaemH, ElrefaeyBH. Response of glycaemic control to extravascular low level laser therapy in type 2 diabetic patients: A randomized clinical trial. Physiother Quart2021;29(4):42–48.
33.
LinaresSN, BeltrameT, GaldinoGA, et al.Dose response effect of photobiomodulation on hemodynamic responses and glucose levels in men with type 2 diabetes: A randomized, crossover, double-blind, sham-controlled trial. In: Photonics. MDPI2022;9(7):481.
34.
FaresH, Abd El-MoneamH, GhanemA, ElrefaeyB, ElyazedT. Effect of Photo-Bio modulation on lipid profile in Patients with type 2 diabetes mellitus: A Randomized Clinical Trial. Journal of Population Therapeutics and Clinical Pharmacology2023;30.
35.
ScontriCMCB, de Castro MagalhãesF, DamianiAPM, HamblinMR, ZamunérAR, FerraresiC. Dose and time–response effect of photobiomodulation therapy on glycemic control in type 2 diabetic patients combined or not with hypoglycemic medicine: A randomized, crossover, double‐blind, sham‐controlled trial. J Biophotonics2023;16(10):e202300083.
36.
WadaJ, NakatsukaA. Mitochondrial dynamics and mitochondrial dysfunction in diabetes. Acta Med Okayama2016;70(3):151–158.
37.
SharmaK. Mitochondrial hormesis and diabetic complications. Diabetes2015;64(3):663–672.
38.
SzendroediJ, PhielixE, RodenM. The role of mitochondria in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol2011;8(2):92–103.
39.
QinB, WangY, DingJ. The role of mitochondrial function in the pathogenesis of diabetes. Front Endocrinol (Lausanne)2025;16:1607641.
40.
KetemaEB, KibretKT. Correlation of fasting and postprandial plasma glucose with HbA1c in assessing glycemic control; systematic review and meta-analysis. Arch Public Health2015;73:43.
41.
DialloA, VillardO, Carlos‐BolumbuM, DucP, GaltierF. Blood glucose and body weight reduction for the prevention of clinical events and mortality in patients with type 2 diabetes: A meta‐analysis and meta‐regression of 44 randomized controlled trials. Diabetes Obes Metab2025;27(9):5118–5126.
42.
Kazemi KhooN, IravaniA, ArjmandM, et al.A metabolomic study on the effect of intravascular laser blood irradiation on type 2 diabetic patients. Lasers Med Sci2013;28(6):1527–1532.
43.
Kazemi KhooN, AnsariF. Blue or red: Which intravascular laser light has more effects in diabetic patients? Lasers Med Sci2015;30(1):363–366.
44.
MomenzadehS, AbbasiM, EbadifarA, AryaniM, BayramiJ, NematollahiF. The intravenous laser blood irradiation in chronic pain and fibromyalgia. J Lasers Med Sci2015;6(1):6–9.
45.
ChangC-C, LiY-H, ChenH-H, SunS-F. Clinical applications and molecular mechanisms for intravenous laser blood irradiation: A systematic review. Lasers Med Sci2025;40(1):416.
46.
da Silva JúniorFL, de Araújo SilvaDN, da Silva AzevedoML, et al.Efficacy of ILIB on periodontal clinical parameters and glycemic control in patients with periodontitis and type II diabetes—randomized clinical trial. Lasers Med Sci2022;37(3):1945–1952.
47.
da Silva TonettoL, da SilvaCCF, GonzattiN, et al.Effects of photobiomodulation on oxidative stress in rats with type 2 diabetes mellitus. Lasers Med Sci2023;38(1):90.
48.
CastroKMR, de Paiva CarvalhoRL, JuniorGMR, et al.Can photobiomodulation therapy (PBMT) control blood glucose levels and alter muscle glycogen synthesis? J Photochem Photobiol B2020;207:111877.
49.
SilvaG, FerraresiC, de AlmeidaRT, et al.Infrared photobiomodulation (PBM) therapy improves glucose metabolism and intracellular insulin pathway in adipose tissue of high-fat fed mice. Lasers Med Sci2018;33(3):559–571.
50.
GuoS, GongL, ShenQ, XingD. Photobiomodulation reduces hepatic lipogenesis and enhances insulin sensitivity through activation of CaMKKβ/AMPK signaling pathway. J Photochem Photobiol B2020;213:112075.
51.
GongL, ZouZ, LiuL, GuoS, XingD. Photobiomodulation therapy ameliorates hyperglycemia and insulin resistance by activating cytochrome c oxidase-mediated protein kinase B in muscle. Aging (Albany NY)2021;13(7):10015–10033.
52.
SinghR, BardenA, MoriT, BeilinL. Advanced glycation end-products: A review. Diabetologia2001;44(2):129–146.
53.
KocakE, SağlamM, KayışSA, et al.Nonsurgical periodontal therapy with/without diode laser modulates metabolic control of type 2 diabetics with periodontitis: a randomized clinical trial. Lasers Med Sci2016;31(2):343–353.
54.
de Oliveira FranciscoC, BeltrameT, HughsonRL, et al.Effects of light-emitting diode therapy (LEDT) on cardiopulmonary and hemodynamic adjustments during aerobic exercise and glucose levels in patients with diabetes mellitus: A randomized, crossover, double-blind and placebo-controlled clinical trial. Complement Ther Med2019;42:178–183.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
